CHEMICALS PHARMA BOOSTS ITS MOVE-IN VOLUMES CHEMICALS & PHARMA BOOSTS ITS MOVE-IN VOLUMES
The relevant moves come largely from Péri-Défense (Arkema, UCB Pharma, Eisai Laboratories, SGD Pharma…), but also from the Outer Suburbs (Sanofi, Solabia) and even Paris CBD (Takeda, Mylan). Just one move-out is recorded: AstraZeneca, moving to a new building of the "Arboretum" programme in Nanterre, in Péri- Défense.
Chemicals-pharma companies now account for 10% of office space leased at La Défense over the past 5 years, compared to only 4% between 2015 and 2019: a step-up that places the sector among the leading drivers of the period. While the number of moves in, around a dozen, is similar across the two periods, the volume, a 73,000 sq m, has more than doubled since 2021.
ORIGIN OF CHEMICALS-PHARMA COMPANIES ESTABLISHED IN LA DÉFENSE OVER THE 2021-2025PERIOD
9%
Péri-Défense
9%
Paris CBD
9%
Southern Loop Western Crescent - Other Northern Inner Suburbs Southern Outer Suburbs
46%
9%
18%
TOP OFFICE TRANSACTIONS IN THE SECTOR BY SIZE
YEAR OF
VOLUME
BUILDING
COMPANY
ORIGIN
10% share of space leased by chemicals and pharmaceutical companies between 2021-2025
TRANSACTION
SQ M
+600 pts vs 2015-2019
Southern Outer Suburbs
SANOFI
2024
CB3
31,464
ARKEMA
2022
LIGHTWELL
25,094
Péri Défense
GILEAD
2024
LEGENDE
3,023
Southern Loop
Western Crescent - Other
ALBEA
2025
CŒUR DÉFENSE
2,278
MYLAN
2021
TRINITY
2,080
Paris CBD
TAKEDA
2025
CB21
1,469
Paris CBD
Source: Cushman & & Wakefield Mid-market (1,000–5,000 sq m) and Large-market (over 5,000 sq m) deals
19
CUS H MAN & WAK EFI ELD
LA DEFENSE MOVES 2026
Powered by FlippingBook